Study of Selumetinib (MK-5618) in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors (MK-5618-001)
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Pembrolizumab (MK-3475) Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630)
- Status
- COMPLETED
- Phase
- PHASE3
Study of Pembrolizumab Following Surgery in Patients With Microsatellite Instability High (MSI-H) Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
HPV Vaccination in Africa- New Delivery Schedules Alias The HANDS HPV Vaccine Trial
- Status
- UNKNOWN
- Phase
- PHASE3
Ceftolozane/Tazobactam (MK-7625A) Plus Metronidazole Versus Meropenem for Participants With Complicated Intra-abdominal Infection (MK-7625A-015)
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) in Adults With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Treatment-naïve Nonsmall Cell Lung Cancer (NSCLC) (MK-7902-007/E7080-G000-314/LEAP-007)
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy Study of Pemetrexed + Platinum Chemotherapy + Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-7902-006/E7080-G000-315/LEAP-006)
- Status
- COMPLETED
- Phase
- PHASE3
Cardiovascular Disease in HIV and Hepatitis C: Risk Outcomes After Hepatitis C Eradication
- Status
- COMPLETED
- Phase
- PHASE4
Safety and Efficacy Study of Pembrolizumab (MK-3475) Combined With Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Advance Melanoma (MK-7902-003/E7080-G000-312/LEAP-003)
- Status
- COMPLETED
- Phase
- PHASE3
Combination Therapy With GEN0101 and Pembrolizmub in Advanced Melanoma Patients PIb/PII
- Status
- UNKNOWN
- Phase
- PHASE2
MRE as a Screening Tool for axSpA in IBD
- Status
- COMPLETED
- Phase
- N/A
RPTR-147 in Patients With Selected Solid Tumors and Lymphomas
- Status
- TERMINATED
- Phase
- PHASE1
Phase II Trial of Pembrolizumab in Recurrent or Metastatic HNSCC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Bevacizumab and Pembrolizumab Combination in Platinum-resistant Recurrent/Metastatic NPC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Approaches To Therapy Escalation In T2D
- Status
- WITHDRAWN
- Phase
- PHASE4
Converting HR+ Breast Cancer Into an Individualized Vaccine
- Status
- RECRUITING
- Phase
- PHASE2
A Study of ASP1951 in Subjects With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)
- Status
- COMPLETED
- Phase
- PHASE2
ATTIC - Access To Treat in the Community
- Status
- TERMINATED
- Phase
- PHASE4
Testing Utility of Commercially Available Sleep Trackers for Physician-Patient Communication
- Status
- UNKNOWN
- Phase
- NA